Inspection Record

Dalton Chemical Laboratories Inc. O/A Dalton Pharma Services — Health Canada Inspection Findings

Health CanadaInspected 2025-10-22 14 findingsEquipment and facilityLaboratory and QC controlsAseptic processing and sterility assuranceOther quality systemDeviation, CAPA, and investigationContamination controlEnvironmental monitoringRegulatory reporting and change controlCleaning validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

2Laboratory and QC controls

The design, equipment, and/or maintenance of the testing laboratory was inadequate. The establishment and/or the maintenance of a data governance plan was inadequate.

3Aseptic processing and sterility assurance

The company did not monitor the steam used for sterilization for suitable quality.

4Other quality system

The suitability of the culture media was not verified.

5Aseptic processing and sterility assurance

The operators'aseptic practices were inadequate to maintain sterility.

6Other quality system

The company's visual inspection of filled containers was inadequate.

7Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate. The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

8Other quality system

The master production documents were inadequate.

9Aseptic processing and sterility assurance

The company did not justify the hold time for sterilized components, containers, or equipment.

10Contamination control

The company did not adequately demonstrate that air-flow patterns did not pose a risk of contamination.

11Environmental monitoring

The number of samples taken for environmental monitoring was insufficient. The environmental sampling methods were inadequate.

12Equipment and facility

The company did not design or maintain the premises and equipment to minimize microbial contamination and the number of airborne particles in clean areas.

13Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

14Cleaning validation

The availability, implementation, and/or quality of the written sanitation program was inadequate. The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination. The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate. The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-10-22. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Dalton Chemical Laboratories Inc. O/A Dalton Pharma Services findings history — including this company's other documents Health Canada documents, 2025 Go to Findings search